Quarterly Results Trend: A Clear Upward Trajectory

The latest data from 1,566 companies that have declared their March 2026 quarter results indicates a steady improvement in earnings quality over the past year. The proportion of companies reporting positive results has increased quarter-on-quarter from 41.0% in June 2025 to 44.0% in September 2025, 46.0% in December 2025, and finally 56.0% in March 2026. This upward trend suggests improving business conditions and better cost management across sectors.

Large-cap companies, often seen as bellwethers of the economy, have shown moderate improvement with 52.0% positive results, up from previous quarters but still trailing mid caps. Mid-cap companies have demonstrated remarkable resilience and growth potential, with two-thirds reporting positive earnings. Small caps, while more volatile, have also improved their earnings performance, with 55.0% positive results.

Sectoral Highlights and Top Performers

Among large caps, Muthoot Finance in the Non-Banking Financial Company (NBFC) sector delivered one of the strongest results, benefiting from sustained demand for gold-backed loans and improved asset quality. The company’s earnings growth has been supported by higher net interest margins and controlled credit costs, reflecting a healthy credit cycle in the NBFC space.

Mid-cap stocks have been led by Multi Commodity Exchange (Multi Comm. Exc.) in the Capital Markets sector, which posted robust volume growth and higher transaction fees amid increased market participation. This has translated into strong operating leverage and margin expansion, underpinning the company’s positive earnings surprise.

In the small-cap segment, Puravankara from the Realty sector stood out with impressive sales bookings and improved collections, signalling a revival in real estate demand. Other notable small-cap performers include Navin Fluorine International in Specialty Chemicals and Navkar Corporation in Transport Services, both of which reported strong revenue growth and margin improvement driven by sector-specific tailwinds.

Outstanding Quarterly Performance: Viyash Scientific Ltd.

Among the recent declarations, Viyash Scientific Ltd., a pharmaceutical and biotechnology company with a market cap of ₹11,013.63 crores, reported an exceptional quarter ending March 2026. The company’s net sales surged by 129.02% to ₹919.96 crores, marking its highest quarterly sales ever. Operating profit to interest ratio reached a peak of 12.69 times, underscoring strong operational efficiency and low leverage.

Profit before tax (excluding other income) soared by an extraordinary 629.29% to ₹109.32 crores, while net profit after tax grew by 446.4% to ₹52.11 crores. The company also recorded its highest PBDIT at ₹184.25 crores, reflecting robust margin expansion. Despite a slight decline in its Mojo score from 35 to 33 over the past three months, Viyash Scientific’s financial performance remains outstanding, signalling strong fundamentals and growth prospects.

Aggregate Profit Growth and Market Implications

The aggregate profit growth across sectors has been driven by a combination of volume recovery, price realisations, and cost rationalisation. Mid-cap companies, in particular, have leveraged their agility and sectoral positioning to capitalise on emerging opportunities, resulting in superior earnings growth compared to their large-cap counterparts. This trend is encouraging for investors seeking growth beyond the traditional blue-chip universe.

Large caps, while showing steady improvement, continue to face challenges from global macroeconomic uncertainties and input cost pressures. However, companies like Muthoot Finance demonstrate that selective sectors within large caps can still deliver strong earnings momentum. Small caps, though more susceptible to volatility, have benefited from sector-specific demand upticks, especially in realty and specialty chemicals.

Upcoming Results to Watch

Market participants will closely monitor the earnings announcements of key companies scheduled for 21 May 2026, including Max Healthcare Institute Ltd, GAIL (India) Ltd, and ITC Ltd. These results are expected to provide further clarity on sectoral trends and corporate earnings sustainability amid evolving economic conditions.

Outlook and Investor Takeaways

The improving trend in quarterly earnings, particularly the strong showing by mid caps, suggests a broadening of growth opportunities in the Indian equity market. Investors may consider increasing exposure to mid-cap stocks with robust fundamentals and positive earnings momentum, while selectively adding large caps with resilient business models and improving profitability.

However, caution remains warranted given the mixed performance across sectors and the potential impact of external factors such as commodity price fluctuations and geopolitical risks. A balanced portfolio approach, combining growth-oriented mid caps and stable large caps, is advisable to navigate the evolving market landscape.

Summary

The March 2026 quarterly results season has delivered encouraging signs of recovery and growth, with 56.0% of companies reporting positive earnings. Mid caps have led the charge with a 66.0% positive result ratio, supported by strong performances in capital markets and realty sectors. Large caps and small caps have also improved, albeit at a more moderate pace. Standout performers like Viyash Scientific Ltd. exemplify the potential for exceptional growth in select companies. As the market awaits key results later this week, investors should focus on quality earnings growth and sectoral leadership to capitalise on the current momentum.